Abstract
Background Premature ventricular contractions (PVCs) during recovery of exercise stress testing are associated with increased cardiovascular mortality, but the cause remains unknown. We aimed to evaluate the association of PVCs during recovery with echocardiographic abnormalities, and their combined prognostic performance.
Methods Echocardiographic abnormalities (reduced left ventricular (LV) ejection fraction, valvular heart disease, LV dilatation, LV hypertrophy, or increased filling pressures) and PVCs during recovery (≥1/min) were identified among patients having undergone echocardiography within median [interquartile range] 0 [0-2] days of an exercise stress test. The association between such changes and cardiovascular mortality was analyzed using Cox regression adjusted for age, sex, clinical and exercise variables.
Results Among included patients (n=3,106), PVCs during recovery were found in 1,327 (43%) patients, among which the prevalence of echocardiographic abnormalities was increased (58% vs. 44%, p<0.001). Overall, PVCs during recovery were associated with increased cardiovascular mortality (219 total events, 7.9 [5.4–11.1] years follow-up; adjusted hazard ratio (HR [95% confidence interval]) 1.6 [1.2–2.1], p<0.001). When combined with echocardiographic abnormalities, PVCs during recovery were associated with increased risk when such were present (HR 3.3 [1.9–5.5], p<0.001) but not when absent (HR 1.5 [0.8–2.8], p=0.22), in reference to those with neither.
Conclusion PVCs during recovery were associated with increased prevalence of echocardiographic abnormalities. Increased risk of cardiovascular mortality was observed only for subjects with PVCs if concomitant echocardiographic abnormalities were present. Our findings provide mechanistic insights to the increased CV risk reported in patients with PVCs during recovery.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
Funding: TL is under the support of postdoctoral research grants from The Swedish Heart-Lung Foundation (grant no 20200553), the Swedish Cardiac Society, the Royal Swedish Academy of Sciences (grant no LM2019-0013), Women and Health Foundation, Region Kronoberg (grant no 8301), The Swedish Heart and Lung Association (grant no LKH1387), Swedish Association of Clinical Physiology, and the Scandinavian Society of Clinical Physiology & Nuclear Medicine. ME is funded by an unrestricted grant from the Swedish Research Council (Dnr: 2019-02081). KH is funded by unrestricted ALF grants from county council of Ostergotland. MU is funded by New South Wales Health, Heart Research Australia, and the University of Sydney.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The study complies with the Declaration of Helsinki and was approved by the Regional Ethical Review Board in Linkoping (Dnr 2012/379-31; 2018/141-31 and 2020/00352). Informed consent was waived by the Ethical Review Board.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Funding: This work was supported by The Swedish Heart-Lung Foundation [grant no 20200553 to TL]; the Swedish Cardiac Society, the Royal Swedish Academy of Sciences [grant no LM2019-0013 to TL]; Women and Health Foundation [TL], Region Kronoberg [grant no 8301 to TL]; The Swedish Heart and Lung Association [grant no LKH1387 to TL]; Swedish Association of Clinical Physiology [TL]; the Scandinavian Society of Clinical Physiology & Nuclear Medicine [TL); the Swedish Research Council [Dnr: 2019-02081 to ME]; unrestricted ALF grants from county council of Östergötland [KH]; New South Wales Health, Heart Research Australia [MU]; and the University of Sydney [TL, MU].
Conflicts of interests: None
Data Availability
All data produced in the present study are available upon reasonable request to the authors
